Severs, M <br/><br/>
The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease.  [electronic resource] 

 -  Journal of Crohn's & colitis  Mar 2017 
 - 289-296 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1093/ecco-jcc/jjw153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--economics<br/>Biosimilar Pharmaceuticals--economics<br/>Colitis, Ulcerative--drug therapy<br/>Computer Simulation<br/>Crohn Disease--drug therapy<br/>Drug Costs--statistics & numerical data<br/>Drug Prescriptions--statistics & numerical data<br/>Drug Substitution--economics<br/>Gastrointestinal Agents--economics<br/>Hospitalization--economics<br/>Humans<br/>Infliximab--economics<br/>Models, Economic<br/>Netherlands